Company / Operating Cash Flow per Share
Anika Therapeutics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.78
FY2025
5-year range
-$0.12 / $2.58
FY2021-FY2025
Trend
+110.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.12 in FY2023 to $2.87 in FY2019.
Based on SEC 10-K filings.
0.78 in FY2025 with a 5-year CAGR of -20.5%.
Improved from $-0.12 to $0.78 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- -20.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 110.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.78 | +110.6% |
| FY2024 | $0.37 | +401.5% |
| FY2023 | -$0.12 | -113.5% |
| FY2022 | $0.90 | -65.0% |
| FY2021 | $2.58 | +5.8% |
| FY2020 | $2.44 | -15.0% |
| FY2019 | $2.87 | +72.5% |
| FY2018 | $1.66 | -39.0% |
| FY2017 | $2.73 | +2.6% |
| FY2016 | $2.66 | +56.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026